Muscle NAD+ depletion and Serpina3n as molecular determinants of murine cancer cachexia-the effects of blocking myostatin and activins
Objective: Cancer cachexia and muscle loss are associated with increased morbidity and mortality. In preclinical animal models, blocking activin receptor (ACVR) ligands has improved survival and prevented muscle wasting in cancer cachexia without an effect on tumour growth. However, the underlying m...
Saved in:
Main Authors: | J.J. Hulmi (Author), F. Penna (Author), N. Pöllänen (Author), T.A. Nissinen (Author), J. Hentilä (Author), L. Euro (Author), J.H. Lautaoja (Author), R. Ballarò (Author), R. Soliymani (Author), M. Baumann (Author), O. Ritvos (Author), E. Pirinen (Author), M. Lalowski (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses
by: Tuuli A. Nissinen, et al.
Published: (2018) -
Inhibition of Activin/Myostatin signalling induces skeletal muscle hypertrophy but impairs mouse testicular development
by: Danielle Vaughan, et al.
Published: (2020) -
A muscle growth-promoting treatment based on the attenuation of activin/myostatin signalling results in long-term testicular abnormalities
by: Danielle Vaughan, et al.
Published: (2021) -
Compression of morbidity in a progeroid mouse model through the attenuation of myostatin/activin signalling
by: Khalid Alyodawi, et al.
Published: (2019) -
Prevention of chemotherapy‐induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle
by: Juha J. Hulmi, et al.
Published: (2018)